SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16137055
Source:
http://linkedlifedata.com/resource/pubmed/id/16137055
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0205174
,
umls-concept:C0850666
pubmed:issue
5
pubmed:dateCreated
2005-9-2
pubmed:abstractText
To evaluate the efficacy of a 5-day rabeprazole-based triple therapy regimen for helicobacter pylori infection, and to improve the eradication rates of antibiotic-resistant Helicobacter pylori with rabeprazole plus clarithromycin and furazolidone.
pubmed:language
chi
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101230586
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin
,
http://linkedlifedata.com/resource/pubmed/chemical/Furazolidone
,
http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1672-7347
pubmed:author
pubmed-author:ChenXiongX
,
pubmed-author:JiaYanY
,
pubmed-author:LiuShao-junSJ
,
pubmed-author:ShenShou-rongSR
,
pubmed-author:TangWu-liangWL
,
pubmed-author:WangFenF
,
pubmed-author:WangXiao-yanXY
,
pubmed-author:XuCan-xiaCX
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
589-91
pubmed:dateRevised
2007-5-15
pubmed:meshHeading
pubmed-meshheading:16137055-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:16137055-Adult
,
pubmed-meshheading:16137055-Anti-Ulcer Agents
,
pubmed-meshheading:16137055-Clarithromycin
,
pubmed-meshheading:16137055-Drug Administration Schedule
,
pubmed-meshheading:16137055-Drug Therapy, Combination
,
pubmed-meshheading:16137055-Female
,
pubmed-meshheading:16137055-Furazolidone
,
pubmed-meshheading:16137055-Gastritis
,
pubmed-meshheading:16137055-Helicobacter Infections
,
pubmed-meshheading:16137055-Helicobacter pylori
,
pubmed-meshheading:16137055-Humans
,
pubmed-meshheading:16137055-Male
,
pubmed-meshheading:16137055-Peptic Ulcer
pubmed:year
2004
pubmed:articleTitle
[Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
pubmed:affiliation
Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
pubmed:publicationType
Journal Article
,
English Abstract
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't